117 related articles for article (PubMed ID: 25889173)
1. A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.
Ellis JJ; Sadosky AB; Ten Eyck LL; Mudumby P; Cappelleri JC; Ndehi L; Suehs BT; Parsons B
BMC Health Serv Res; 2015 Apr; 15():159. PubMed ID: 25889173
[TBL] [Abstract][Full Text] [Related]
2. Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgia.
Ellis JJ; Sadosky AB; Ten Eyck LL; Cappelleri JC; Brown CR; Suehs BT; Parsons B
Clinicoecon Outcomes Res; 2014; 6():389-99. PubMed ID: 25339847
[TBL] [Abstract][Full Text] [Related]
3. Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators.
Marlow NM; Simpson KN; Vaughn IA; Jo A; Zoller JS; Short EB
Pain Pract; 2018 Feb; 18(2):154-169. PubMed ID: 28419725
[TBL] [Abstract][Full Text] [Related]
4. A secondary analysis of PAIN-CONTRoLS: Pain's impact on sleep, fatigue, and activities of daily living.
Bhai SF; Brown A; Gajewski B; Kimminau KS; Waitman LR; Pasnoor M; Barohn RJ;
Muscle Nerve; 2022 Oct; 66(4):404-410. PubMed ID: 35585718
[TBL] [Abstract][Full Text] [Related]
5. Diabetic Peripheral Neuropathy: Prevention and Treatment.
Bragg S; Marrison ST; Haley S
Am Fam Physician; 2024 Mar; 109(3):226-232. PubMed ID: 38574212
[TBL] [Abstract][Full Text] [Related]
6. Conventional management and current guidelines for painful diabetic neuropathy.
Tesfaye S; Kempler P
Diabetes Res Clin Pract; 2023 Dec; 206 Suppl 1():110765. PubMed ID: 38245323
[TBL] [Abstract][Full Text] [Related]
7. Treatment-induced neuropathy of diabetes: challenges in diagnosing neuropathic pain, value of sudomotor function testing.
Abdelhamid S; Shabani M; Russjan A; Tarnutzer AA
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37967926
[TBL] [Abstract][Full Text] [Related]
8. Drug-Drug Interactions and Their Association with Adverse Health Outcomes in the Older Community-Dwelling Population: A Prospective Cohort Study.
Hughes JE; Bennett KE; Cahir C
Clin Drug Investig; 2024 Jun; 44(6):439-453. PubMed ID: 38878216
[TBL] [Abstract][Full Text] [Related]
9. Perceptions of Painful Diabetic Peripheral Neuropathy in South-East Asia: Results from Patient and Physician Surveys.
Malik RA; Aldinc E; Chan SP; Deerochanawong C; Hwu CM; Rosales RL; Yeung CY; Fujii K; Parsons B
Adv Ther; 2017 Jun; 34(6):1426-1437. PubMed ID: 28502036
[TBL] [Abstract][Full Text] [Related]
10. Channeling of New Neuropsychiatric Drugs-Impact on Safety and Effectiveness Studies.
Abraham DS; Nguyen TPP; Blank LJ; Thibault D; Gray SL; Hennessy S; Leonard CE; Weintraub D; Willis AW
Neurotherapeutics; 2023 Mar; 20(2):375-388. PubMed ID: 36864331
[TBL] [Abstract][Full Text] [Related]
11. Antineuropathic Pain Management After Orthopedic Surgery: A Systematic Review.
Harder T; Harder J; Baum G; Cox C; Harder J; Hernandez E; MacKay B
Orthop Rev (Pavia); 2024; 16():93012. PubMed ID: 38505138
[TBL] [Abstract][Full Text] [Related]
12. The impact of a restricted pregabalin prescription policy on drug utilization: An observational multicenter study.
Al-Jedai A; Alkofide H; Almohimeed L; Alsalim L; Alruwaili A; Alissa DA; Almudaiheem H
Saudi Pharm J; 2023 Dec; 31(12):101851. PubMed ID: 38028223
[TBL] [Abstract][Full Text] [Related]
13. Potential Drug-Drug Interactions and Related Factors among Geriatric Outpatients of a Tertiary Care Hospital.
Wannawichate T; Limpawattana P
Geriatrics (Basel); 2023 Nov; 8(6):. PubMed ID: 37987471
[TBL] [Abstract][Full Text] [Related]
14. DDD-028: A potent, neuroprotective, non-opioid compound for the treatment of diabetic neuropathy.
Micheli L; Rajamoni J; Di Cesare Mannelli L; Rajagopalan P; Ghelardini C; Rajagopalan R
Bioorg Med Chem Lett; 2023 Oct; 95():129472. PubMed ID: 37690597
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine may have clinical value: comment on the article by van den Driest et al.
Block JA; Pincus T
Arthritis Rheumatol; 2022 Nov; 74(11):1859-1860. PubMed ID: 35791999
[No Abstract] [Full Text] [Related]
16. Potential role of pregabalin in the treatment of episodic breathlessness.
Gaertner J; Witte KK
Ann Palliat Med; 2024 Jan; 13(1):200-201. PubMed ID: 38073296
[No Abstract] [Full Text] [Related]
17. Neuropathic pain in elderly patients with chronic low back painand effects of pregabalin: a preliminary study.
Sakai Y; Ito K; Hida T; Ito S; Harada A
Asian Spine J; 2015 Apr; 9(2):254-62. PubMed ID: 25901238
[TBL] [Abstract][Full Text] [Related]
18. Diabetic neuropathic pain: Physiopathology and treatment.
Schreiber AK; Nones CF; Reis RC; Chichorro JG; Cunha JM
World J Diabetes; 2015 Apr; 6(3):432-44. PubMed ID: 25897354
[TBL] [Abstract][Full Text] [Related]
19. Impact of pregabalin on the occurrence of postthoracotomy pain syndrome: a randomized trial.
Brulotte V; Ruel MM; Lafontaine E; Chouinard P; Girard F
Reg Anesth Pain Med; 2015; 40(3):262-9. PubMed ID: 25899956
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
